Mustafa Tarkan Aksozen
Research Subjects
Mustafa Tarkan Aksozen has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Dicle Aslan
Department of Radiation Oncology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
2 shared publications - Celalettin Eroğlu
Department of Radiation Oncology, Erciyes University Medical Faculty, Kayseri, Turkey
1 shared publication - Esin Kiraz
Faculty of Medicine, Department of Radiation Oncology Erciyes University Kayseri Turkey
1 shared publication - Mete Gundog
Faculty of Medicine, Department of Radiation Oncology Erciyes University Kayseri Turkey
1 shared publication - Oktay Bozkurt
Department of Medical Oncology, Erciyes University, Kayseri 38039, Turkey
1 shared publication - Ummuhan Abdulrezzak
Erciyes University, Medicine School, Department of Nuclear Medicine, Kayseri, Türkiye
1 shared publication
Latest Publications
- 15 December 2025
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 15 (4) , 402-410
DOSIMETRIC ANALYSIS OF DEEP INSPIRATION BREATH HOLD TECHNIQUE ADAPTED TO TANGENTIAL-BASED VOLUMETRIC MODULATED ARC THERAPY FOR LEFT BREAST CANCER AFTER MASTECTOMY
Purpose: To evaluate the dosimetric properties of the deep inspiration breath hold (DIBH) technique adapted to tangential-based volumetric modulated arc therapy (TVMAT) in left breast cancer patients with mastectomy. Method: Forty-three patients who underwent mastectomy and received chest wall and regional lymph node irradiation were included in the study. Simulation computed tomography (CT) was performed in DIBH and free-breathing (FB). Two plans were created for each patient; DIBH-TVMAT and FB-TVMAT. Both plans were realized using a mono-isocentric technique with two partial arc rotations, and the same gantry angles were used.The standard fractionation schedule for each patient was set to 50 Gy in 25 fractions. Paired-sample T-test was used to evaluate the dosimetric parameters. Results: The comparison between FB-TVMAT and DIBH-TVMAT plans revealed mean heart doses of 8.9 Gy and 5.4 Gy, respectively (p=0.000). A 6.2% reduction was encountered in left lung volume receiving 5 Gy (V5) in the DIBH-TVMAT plan (p=0.01). A reduction of 1.3 Gy at a percentage of 28% was monitored in the mean dose of the right lung in DIBH-TVMAT (p=0.000). The mean right breast dose was 0.7 Gy lower in DIBH-TVMAT (p=0.000). Conclusion: The results support that the adaptation of DIBH to TVMAT allows an optimal target volume dose coverage as well as leads to significant dose reductions in the left lung, right lung, heart, LADCA, and right breast for the left breast cancer patients with mastectomy.
- 15 December 2025
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 15 (4) , 402-410
DOSIMETRIC ANALYSIS OF DEEP INSPIRATION BREATH HOLD TECHNIQUE ADAPTED TO TANGENTIAL-BASED VOLUMETRIC MODULATED ARC THERAPY FOR LEFT BREAST CANCER AFTER MASTECTOMY
Purpose: To evaluate the dosimetric properties of the deep inspiration breath hold (DIBH) technique adapted to tangential-based volumetric modulated arc therapy (TVMAT) in left breast cancer patients with mastectomy. Method: Forty-three patients who underwent mastectomy and received chest wall and regional lymph node irradiation were included in the study. Simulation computed tomography (CT) was performed in DIBH and free-breathing (FB). Two plans were created for each patient; DIBH-TVMAT and FB-TVMAT. Both plans were realized using a mono-isocentric technique with two partial arc rotations, and the same gantry angles were used.The standard fractionation schedule for each patient was set to 50 Gy in 25 fractions. Paired-sample T-test was used to evaluate the dosimetric parameters. Results: The comparison between FB-TVMAT and DIBH-TVMAT plans revealed mean heart doses of 8.9 Gy and 5.4 Gy, respectively (p=0.000). A 6.2% reduction was encountered in left lung volume receiving 5 Gy (V5) in the DIBH-TVMAT plan (p=0.01). A reduction of 1.3 Gy at a percentage of 28% was monitored in the mean dose of the right lung in DIBH-TVMAT (p=0.000). The mean right breast dose was 0.7 Gy lower in DIBH-TVMAT (p=0.000). Conclusion: The results support that the adaptation of DIBH to TVMAT allows an optimal target volume dose coverage as well as leads to significant dose reductions in the left lung, right lung, heart, LADCA, and right breast for the left breast cancer patients with mastectomy.
- Open Access
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Dosimetric comparison of IMRT, VMAT, and hybrid techniques in stereotactic body radiotherapy for adrenal metastases
Stereotactic body radiotherapy (SBRT) has emerged as a non-invasive alternative for the treatment of adrenal metastases, increasingly replacing traditional invasive approaches. However, its clinical application remains under investigation. The introduction of advanced radiotherapy techniques has further fueled interest in SBRT, necessitating comprehensive dosimetric evaluations to optimize treatment strategies. This study compares three distinct SBRT techniques: pure intensity-modulated radiotherapy (IMRT), pure volumetric modulated arc therapy (VMAT), and a hybrid approach combining VMAT and IMRT, utilizing flattening filter-free (FFF) photon beams. Treatment plans were assessed using dosimetric distributions, dose-volume histograms (DVH), homogeneity index (HI), and conformity index (CI). Repeated-measures analysis of variance (ANOVA) was performed, with statistical significance set at p < 0.05. Both VMAT and hybrid plans demonstrated superior CI and HI values compared to IMRT. However, the maximum dose (Dmax) to the planning target volume (PTV) was lower in the hybrid plan than in VMAT but comparable to IMRT. Additionally, critical organ dose analyses revealed that VMAT and hybrid plans achieved significantly lower doses in the renal cortex (Dmax and V17.5), duodenum (Dmax and V12.5), aorta (Dmax), and stomach (Dmax) compared to IMRT. The findings indicate that both VMAT and hybrid techniques outperform IMRT, offering improved plan quality and superior critical organ sparing. These results highlight the potential clinical advantages of VMAT and hybrid SBRT approaches in the treatment of adrenal metastases. Further clinical validation through large-scale studies is warranted to establish the optimal treatment strategy.
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessDosimetric comparison of IMRT, VMAT, and hybrid techniques in stereotactic body radiotherapy for adrenal metastases
Stereotactic body radiotherapy (SBRT) has emerged as a non-invasive alternative for the treatment of adrenal metastases, increasingly replacing traditional invasive approaches. However, its clinical application remains under investigation. The introduction of advanced radiotherapy techniques has further fueled interest in SBRT, necessitating comprehensive dosimetric evaluations to optimize treatment strategies. This study compares three distinct SBRT techniques: pure intensity-modulated radiotherapy (IMRT), pure volumetric modulated arc therapy (VMAT), and a hybrid approach combining VMAT and IMRT, utilizing flattening filter-free (FFF) photon beams. Treatment plans were assessed using dosimetric distributions, dose-volume histograms (DVH), homogeneity index (HI), and conformity index (CI). Repeated-measures analysis of variance (ANOVA) was performed, with statistical significance set at p < 0.05. Both VMAT and hybrid plans demonstrated superior CI and HI values compared to IMRT. However, the maximum dose (Dmax) to the planning target volume (PTV) was lower in the hybrid plan than in VMAT but comparable to IMRT. Additionally, critical organ dose analyses revealed that VMAT and hybrid plans achieved significantly lower doses in the renal cortex (Dmax and V17.5), duodenum (Dmax and V12.5), aorta (Dmax), and stomach (Dmax) compared to IMRT. The findings indicate that both VMAT and hybrid techniques outperform IMRT, offering improved plan quality and superior critical organ sparing. These results highlight the potential clinical advantages of VMAT and hybrid SBRT approaches in the treatment of adrenal metastases. Further clinical validation through large-scale studies is warranted to establish the optimal treatment strategy.